RETRACTION: RETRACTED: Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial (Retraction of Vol 102, Pg 1357, 2014)

被引：1
|
作者：
Kumar, Ashok [1 ]
Begum, Nargis
Prasad, Sudha
Aggarwal, Sarita
Sharma, Shashi
机构：
[1] Maulana Azad Med Coll, Dept Obstet & Gynecol, New Delhi, India
来源：
FERTILITY AND STERILITY | 2023年 / 119卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2023.02.001
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：518 / 518
页数：1
相关论文
共 50 条
  • [21] Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial
    Hamel, Charlotte
    Coppus, Sjors
    van den Berg, Joyce
    Hink, Esther
    van Seeters, Jacoba
    van Kesteren, Paul
    Merien, Ashley
    Torrenga, Bas
    van de Laar, Rafli
    van Scheltinga, Josien Terwisscha
    Gaugler-Senden, Ingrid
    Graziosi, Peppino
    van Rumste, Minouche
    Nelissen, Ewka
    Vandenbussche, Frank
    Snijders, Marcus
    ECLINICALMEDICINE, 2021, 32
  • [22] Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial (vol 396, pg 779, 2020)
    Shahar-Nissan, K.
    Pardo, J.
    Peled, O.
    LANCET, 2020, 396 (10257): : 1070 - 1070
  • [23] The Effect of Anthelmintic Treatment During Pregnancy on HIV Plasma Viral Load: Results From a Randomized, Double-Blind, Placebo-Controlled Trial in Uganda
    Webb, Emily L.
    Kyosiimire-Lugemwa, Jacqueline
    Kizito, Dennison
    Nkurunziza, Peter
    Lule, Swaib
    Muhangi, Lawrence
    Muwanga, Moses
    Kaleebu, Pontiano
    Elliott, Alison M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (03) : 307 - 313
  • [24] RETRACTION: Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: A double blind randomized placebo controlled trial (Retraction of Vol 198, Pg 100, 2016)
    Shehata, Nesreen A. A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2019, 240 : 387 - 387
  • [25] RETRACTION: Treatment of postoperative emetic symptoms with granisetron in women undergoing abdominal hysterectomy: A randomized, double-blind, placebo-controlled, dose-ranging study (Retraction of Vol 65, Pg 321, 2004)
    Fujii, Yoshitaka
    Tanaka, Hiroyoshi
    Somekawa, Yoshiaki
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2018, 88 : 53 - 53
  • [26] RETRACTION: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level (Retraction of Vol 269, Pg 125, 2004)
    Parsanezhad, Mohammad Ebrahim
    Alborzi, Saeed
    Jahromi, Bahia Namavar
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 309 (02) : 729 - 729
  • [27] Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: A double-blind, placebo-controlled, randomized study (Retraction of vol 61, pg 456j, 2006)
    Safarinejad, M. R.
    Hosseini, S. Y.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (01) : 216 - 216
  • [28] Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial
    Norgaard-Pedersen, Caroline
    Nielsen, Kaspar
    Steffensen, Rudi
    Eriksen, Line
    Jorgensen, Malene Moller
    Kesmodel, Ulrik Schioler
    Christiansen, Ole Bjarne
    BMJ OPEN, 2022, 12 (09):
  • [29] Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial
    Cheung, Ka Wang
    Seto, Mimi Tin Yan
    Ng, Ernest Hung Yu
    TRIALS, 2020, 21 (01)
  • [30] Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial
    Ka Wang Cheung
    Mimi Tin Yan Seto
    Ernest Hung Yu Ng
    Trials, 21
12345